Enhabit, Inc. (NYSE:EHAB) Shares Acquired by Systematic Financial Management LP

Systematic Financial Management LP increased its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 12.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,838,199 shares of the company's stock after purchasing an additional 199,235 shares during the quarter. Systematic Financial Management LP owned 3.66% of Enhabit worth $14,522,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AREX Capital Management LP raised its position in Enhabit by 2.5% in the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company's stock valued at $22,056,000 after purchasing an additional 59,353 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Enhabit by 1.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company's stock valued at $15,669,000 after buying an additional 26,753 shares during the period. Paradice Investment Management LLC lifted its stake in Enhabit by 0.7% during the 2nd quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company's stock worth $13,603,000 after acquiring an additional 11,128 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in Enhabit by 52.3% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company's stock valued at $4,306,000 after acquiring an additional 178,000 shares during the period. Finally, Bank of New York Mellon Corp grew its position in Enhabit by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company's stock valued at $3,573,000 after acquiring an additional 5,936 shares in the last quarter.

Enhabit Stock Down 3.2 %

EHAB traded down $0.25 on Friday, hitting $7.74. 341,516 shares of the company were exchanged, compared to its average volume of 575,983. The firm has a 50-day moving average price of $7.46 and a two-hundred day moving average price of $8.33. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74. The company has a market cap of $388.95 million, a price-to-earnings ratio of -3.33 and a beta of 1.89.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the firm posted $0.03 earnings per share. On average, equities analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Analyst Ratings Changes

Separately, Leerink Partners reissued a "market perform" rating and set a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $9.25.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.